Association of FGFR4 Mutation With Immunotherapy Outcomes in Patients With Cancer

被引:0
|
作者
Cui, L. [1 ]
Zhang, Y. [1 ]
Zhao, Z. [2 ]
Bai, Y. [1 ]
Liu, L. [3 ]
机构
[1] 3D Med Inc, Dept Med, Shanghai, Peoples R China
[2] 3D Med Inc, Shanghai, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China
关键词
FGFR4; immunotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P75.07
引用
收藏
页码:S576 / S576
页数:1
相关论文
共 50 条
  • [41] Exploring the involvement of FGFR4 in hepatocellular carcinoma
    Ho, Han Kiat
    Pok, Sharon
    Ruhe, Jens E.
    Hart, Stefan
    Streit, Sylvia S.
    Loo, Hooi Linn
    Foo, Priscilla
    Do Aung, Myat
    Ullrich, Axel
    Lim, Seng Gee
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3549S - 3550S
  • [42] Investigation of FGFR4 (Gly388Arg) Gene Polymorphism in Primary Lung Cancer Patients
    Ture, Mehmet
    Yakut, Tahsin
    Deligonul, Adem
    Karkucak, Mutlu
    Sag, Sebnem Ozemri
    Hartavi, Mustafa
    Cubukcu, Erdem
    Gulten, Tuna
    Evrensel, Turkkan
    INTERNATIONAL JOURNAL OF HUMAN GENETICS, 2015, 15 (01) : 7 - 12
  • [43] Novel Regulatory Factors and Small-Molecule Inhibitors of FGFR4 in Cancer
    Liu, Yanan
    Wang, Canwei
    Li, Jifa
    Zhu, Jiandong
    Zhao, Chengguang
    Xu, Huanhai
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [44] FGFR1-4 mutations are associated with immunotherapy outcomes in patients with non-small cell lung cancer
    Chen, J.
    Yang, H.
    Song, Y.
    Cui, L.
    Zhao, Z.
    Bai, Y.
    Miao, F.
    ANNALS OF ONCOLOGY, 2020, 31 : S1081 - S1081
  • [45] HFE, MTHFR, and FGFR4 genes polymorphisms and breast cancer in Brazilian women
    Batschauer, Anna P.
    Cruz, Nathalia G.
    Oliveira, Vanessa C.
    Coelho, Fernanda F.
    Santos, Izabela R.
    Alves, Michelle T.
    Fernandes, Ana P.
    Carvalho, Maria G.
    Gomes, Karina B.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 357 (1-2) : 247 - 253
  • [46] FGFR4 Splice Variants in Adrenocortical Carcinomas
    Furlan, Karina
    Boyle, Theresa
    Saeed-Vafa, Daryoush
    LABORATORY INVESTIGATION, 2023, 103 (03) : S487 - S487
  • [47] The Role FGFR4 in Pancreatic Endocrine Tumors
    Serra, S.
    Ezzat, S.
    Chetty, R.
    Asa, S. L.
    MODERN PATHOLOGY, 2009, 22 : 120A - 120A
  • [48] FGFR4: A promising therapeutic target for breast cancer and other solid tumors
    Levine, Kevin M.
    Ding, Kai
    Chen, Lyuqin
    Oesterreich, Steffi
    PHARMACOLOGY & THERAPEUTICS, 2020, 214
  • [49] Involvement of FGFR4 in Pulmonary Fibrosis Pathophysiology
    Ghanem, M.
    Justet, A.
    Jaillet, M.
    Hachem, M.
    Boghanim, T.
    Vadel, A.
    Mailleux, A.
    Crestani, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [50] Molecular mechanisms of the anti-cancer drug, LY2874455, in overcoming the FGFR4 mutation-based resistance
    Dehghanian, Fariba
    Alavi, Shahryar
    SCIENTIFIC REPORTS, 2021, 11 (01)